ENS breaks through $22
Market data indicates that ENS has surpassed $22 and is currently trading at $22.41, marking a daily increase of 23.8%. Please exercise caution and implement effective risk management strategies as the market for ENS is experiencing significant volatility.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Report: Anthropic Plans to Grant CEO Amodei Super Voting Rights
Anthropic plans to grant supervoting rights to CEO Dario Amodei and other co-founders to ensure that the founding team can continue to lead the company after it goes public. As Amodei holds only about 2% of the shares, the supervoting rights are intended to strengthen his control. The company will also maintain a non-shareholder trustee structure, giving trustees the power to elect the majority of the board members.
Hansen appoints TechnologyOne COO Stuart MacDonald as CEO effective Nov. 19
Disc Medicine CEO John D. Quisel disposes of USD 2.63 million in common shares